As principal investigator in the Nanomedicine and Extracellular Vesicles Lab, Dr. Wolfram leads a team that is advancing nanomedicine research. Her team's discoveries could ultimately lead to increased therapeutic efficacy and reduced side effects of treatment for breast cancer, liver damage and other conditions.
Learn more about Dr. Wolfram and a key member of her research team in the Nanomedicine and Extracellular Vesicles Lab at Mayo Clinic.
Joy Emelie (Joy) V. Wolfram, Ph.D.
Dr. Wolfram is a faculty member in the Department of Transplantation at Mayo Clinic in Jacksonville, Florida.
Dr. Wolfram also holds positions with several other institutions, including faculty and professorship appointments. Learn more about Dr. Wolfram's professional highlights.
Dr. Wolfram is the author of numerous scientific publications and has received several scientific awards from around the world.
In 2016, she was named in the Amgen Scholars Ten to Watch List, which highlights the best and brightest up-and-comers in science and medicine. In 2017, Dr. Wolfram was selected together with Nobel laureates, prominent authors and professional athletes to represent one of 12 internationally accomplished Finns in the 2017 Inspired in Finland campaign celebrating Finland's 100 years of independence.
Neha S. Shukla, M.S.
Neha S. Shukla, M.S., serves as a special project associate in the Nanomedicine and Extracellular Vesicles Laboratory. Her research focus is the development of extracellular vesicle therapeutics for liver regeneration.
Shukla has more than five years of experience in the pharmaceutical industry and has extensive knowledge of cell and molecular biology techniques. She received her bachelor's and master's degrees in biochemistry from Gujarat University in Gujarat, India.
Taylor Ticer, B.S.
Taylor Ticer is researching how extracellular vesicles can be used for restoring the intrinsic regenerative properties of the liver in patients with liver damage.
Ticer graduated from the University of North Florida in 2017 with a bachelor's degree in biology with a concentration in biomedical sciences. She previously studied the effects of increased antibiotic exposure on the expression of outer membrane proteins in Klebsiella pneumonia.
George Vilanilam, M.B.B.S.
Dr. George Koshy Vilanilam is working on the delivery of nanoparticles to the brain.
Dr. Vilanilam completed medical school in 2015 at the Christian Medical College in India. His primary interest is in neurology, and he has experience working at neurointensive care units in India and at hospitals in the United States. He has presented research topics on the weekend effect for stroke. Dr. Vilanilam is pursuing research to prepare for a residency career in neurology as a clinician-scientist.
Sara Busatto, M.S.
Sara Busatto is a visiting Ph.D. student from the University of Brescia in Italy. Her research in Dr. Wolfram's lab focuses on exploring the targeting and drug delivery capacity of extracellular vesicles in vitro and in vivo. In particular, she is studying the interface between extracellular vesicles and biological membranes, focusing on the blood-brain barrier.
Busatto graduated from the University of Brescia in 2015 with a master's degree in medical biotechnology. She has several publications in the field of extracellular vesicles.